Spoken Alpha
Profound Medical Corp.
Profound Medical designs and operates MRI-guided ultrasound ablation systems for incision-free treatment of prostate disease and other conditions.
Profound Medical Corp is a Healthcare company operating in Medical Devices with a $207.5M market cap.
PROF beat consensus EPS by 1.0% in Q2 FY2026, reported Aug 5, 2026.
20 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PROF.
$ curl https://api.spokenalpha.com/v1/companies/PROFFAQ
Spoken Alpha indexes PROF's earnings call transcripts at https://spokenalpha.com/companies/PROF. Each call links to attributed speakers and parsed analyst Q&A. Profound Medical Corp.'s own investor relations page is at https://ir.profoundmedical.com/.
Profound Medical Corp. (PROF) held its most recent earnings call on 2026-03-06, covering fiscal Q4 2025.
Profound Medical Corp. (PROF) operates in the Healthcare sector (Medical Devices industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-05 | $0.26 | $-0.22 | +100.0% | $2.5M | — | — | EODHD |
| Q1 FY2026 | 2026-05-06 | $-0.19 | $-0.25 | +24.0% | $5.3M | — | — | EODHD |
| Q4 FY2025 | 2026-03-09 | $-0.27 | $-0.30 | +10.6% | $6.0M | — | — | EODHD |
| Q3 FY2025 | 2025-11-12 | $-0.26 | $-0.38 | +31.6% | $5.3M | — | — | EODHD |
| Q2 FY2025 | 2025-08-13 | $-0.52 | $-0.40 | -30.0% | $2.2M | — | — | EODHD |
| Q1 FY2025 | 2025-05-07 | $-0.36 | $-0.28 | -28.6% | $2.6M | — | — | EODHD |
| Q4 FY2024 | 2025-03-04 | $-0.20 | $-0.32 | +38.0% | $4.1M | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $-0.38 | $-0.30 | -26.7% | $2.8M | — | — | EODHD |
| Q2 FY2024 | 2024-08-07 | $-0.28 | $-0.28 | 0.0% | $2.2M | — | — | EODHD |
| Q1 FY2024 | 2024-05-08 | $-0.26 | $-0.31 | +16.1% | $1.4M | — | — | EODHD |
| Q4 FY2023 | 2024-03-06 | $-0.42 | $-0.32 | -31.3% | $2.7M | — | — | EODHD |
| Q3 FY2023 | 2023-11-01 | $-0.26 | $-0.32 | +18.8% | $1.7M | — | — | EODHD |
| Q2 FY2023 | 2023-08-08 | $-0.35 | $-0.34 | -2.9% | $1.6M | — | — | EODHD |
| Q1 FY2023 | 2023-05-09 | $-0.32 | $-0.34 | +5.9% | $1.9M | — | — | EODHD |
| Q4 FY2022 | 2023-03-06 | $-0.46 | $-0.36 | -27.8% | $1.7M | — | — | EODHD |
| Q3 FY2022 | 2022-11-02 | $-0.24 | $-0.38 | +36.8% | $2.8M | — | — | EODHD |
| Q2 FY2022 | 2022-08-03 | $-0.28 | $-0.39 | +28.2% | $2.0M | — | — | EODHD |
| Q1 FY2022 | 2022-05-08 | $-0.40 | $-0.43 | +7.0% | $1.7M | — | — | EODHD |
| Q4 FY2021 | 2022-03-02 | $-0.49 | $-0.37 | -32.4% | $1.3M | — | — | EODHD |
| Q3 FY2021 | 2021-11-03 | $-0.29 | $-0.30 | +3.3% | $3.2M | — | — | EODHD |
Source: EODHD. PROF reported actuals as published; sparse fields render as —.